News from the MCRC
MCRC Blog
06/07/2022
Forging Collaborations on an International Scale – MCRC Visit Kenya
Members of the MCRC, University of Manchester and The Christie visited KUTRRH in June to build on existing collaborations to improve cancer survival.
Director's Update
29/06/2022
MCRC Director’s Update – June 2022
In June 2022, the MCRC celebrates research presented at ASCO 2022, as well as our team visiting Kenya to continue the development of our ongoing research collaboration.
MCRC Blog
27/06/2022
Early detection in hereditary cancers
We speak to Dr Emma Woodward about a cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC)
Training and Development
16/06/2022
MB-PhD Summer Placements 2022
Training and Development
07/06/2022
MCRC-DCS Postgraduate Research Showcase 2022
Held on the 12th-13th May 2022, members of the organising committee reflect on the first annual MCRC-DCS Postgraduate Research Showcase.
MCRC Blog
06/06/2022
Is Pursuing ‘a Passion for Science’ a Position of Privilege?
Research Spotlight
06/06/2022
Study identifies best treatment for rare childhood cancer
Dr Martin McCabe presented the results of the rEECur study into recurrent and primary refractory Ewing sarcoma at the 2022 American Society of Clinical Oncology
MCRC Blog
31/05/2022
#PrideInResearch at the MCRC – HPV screening for all
MCRC Blog
30/05/2022
Professor Tim Illidge awarded a Fellowship of The Academy of Medical Sciences
Professor Tim Illidge has been recognised for his contributions to radiotherapy and lymphoma research
Director's Update
30/05/2022
MCRC Director’s Update – May 2022
Impact Case Study
The Case for Banning Sunbeds
A multi-disciplinary team of researchers across Manchester and Australia have been working to assess the cost-effectiveness of this policy-based intervention in reducing the burden of skin cancer on the NHS.
Impact Case Study
PROCAS 2
Impact Case Study
PROCAS and BC-PREDICT
We speak to Professor Gareth Evans about how the findings from PROCAS 1 led to the inception of PROCAS 2, which assesses the feasibility of implementing a personalised risk score into a woman’s first screening appointment and the associated impact on NHS staff, patients and other related organisations.
Partner News
10/05/2022
Indoor tanning ban would reduce melanoma deaths, show researchers
